ASX Announcement

HREC Approval for Redesigned IRX-211 Phase 2 Trial

Published: 03/06/25, 02:59pm (AEST)2 pages
Nexalis Therapeutics
NX1:ASXHealthcare

Recent NX1 Announcements

Price Sensitive only